Skip to main content

Table 2 The course of PCOS-specific serum parameters in the CC and the control groups. Comparison of baseline to two-month follow-up values

From: Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study

Parameter

CC group (n = 41)

Control group (n = 24)

Baseline

After two months of CC stimulation

Delta

p

Baseline

After two months

Delta

p

LH (mU/mL)

11.8 ± 4.9

10.9 ± 4.0

−0.9 ± 2.8

0.029

13.0 ± 6.0

12.3 ± 5.5

− 0.68 ± 2.4

0.174

FSH (mU/mL)

5.9 ± 1.8

5.9 ± 1.4

0.1 ± 1.5

0.787

6.2 ± 1.5

5.5 ± 1.2

− 0.64 ± 1.7

0.072

LH:FSH ratio

2.1 ± 0.8

1.8 ± 0.5

− 0.2 ± 0.6

0.007

2.1 ± 0.8

2.1 ± 0.8

−0.05 ± 0.6

0.643

Total testosterone (ng/mL)

0.43 ± 0.15

0.43 ± 1.55

0.02 ± 0.11

0.651

0.44 ± 0.15

0.46 ± 0.12

0.02 ± 0.08

0.223

Free testosterone (ng/mL)

0.30 ± 0.21

0.27 ± 0.18

−0.03 ± 0.14

0.314

0.30 ± 0.19

0.26 ± 0.12

−0.03 ± 0.14

0.241

Androstenedione (ng/mL)

2.77 ± 1.25

3.23 ± 1.11

0.29 ± 0.76

0.216

3.01 ± 1.13

2.97 ± 0.93

−0.04 ± 0.80

0.801

SHBG (nmol/L)

46.0 ± 20.2

51.2 ± 21.0

5.2 ± 5.7

< 0.001

44.2 ± 27.3

43.0 ± 22.0

−1.2 ± 8.5

0.500

AMH (ng/mL)

8.08 ± 4.27

7.17 ± 3.37

−0.9 ± 2.1

0.011

8.07 ± 4.25

7.97 ± 4.18

−0.10 ± 1.1

0.654

  1. Data are provided as mean ± standard deviation for numerical parameters or numbers (frequency) for categorical parameters; differences between groups were tested using paired t-tests